NCT00303732
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,038 public trials
1,176 recruiting studies
Adenocarcinoma trial results
NCT00227760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- London Regional Cancer Program London, Ontario, Canada
NCT00055692
- Conditions
- Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +11 more
- Locations
-
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
NCT01014065
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada
NCT02150746
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +17 more
- Locations
-
- Shands Hospital at the University of Florida Gainesville, Florida, United States
NCT01539681
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Many Locations, Italy
NCT00027807
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT01426880
- Conditions
- Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
- Locations
-
- Praxis Dr. Heinrich Fürstenwalde, Brandenburg, Germany
- Luisenkrankenhaus Düsseldorf, North Rhine-Westphalia, Germany
- NCT Heidelberg Heidelberg, Germany
Completed
Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma
NCT01594125
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- 1199.120.001 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan
- 1199.120.005 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan
- 1199.120.002 Boehringer Ingelheim Investigational Site Kashiwa, Chiba, Japan
- 1199.120.003 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan
NCT00334282
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- GSK Investigational Site Capital Federal, Buenos Aires, Argentina
- GSK Investigational Site Córdoba, Córdoba Province, Argentina
- GSK Investigational Site Rosario, Santa Fe Province, Argentina
- GSK Investigational Site Quilmes, Argentina